Recent Posts
We’ve known for a while that tirzepatide produces superior weight loss compared to other GLP-1 medications. The question ...
In February and April 2026, the regulatory landscape for compounded peptides shifted significantly. HHS Secretary Robert F. Kennedy ...
Mark your calendar: July 23–24, 2026. That’s when the FDA’s Pharmacy Compounding Advisory Committee (PCAC) convenes to review ...
The debate between tirzepatide and semaglutide has dominated GLP-1 conversations for three years. Anecdotes, clinical trials, and forum ...
You’re three weeks into a BPC-157 protocol. It’s working — your knee feels better than it has in ...
When we first designed the My Daily Peptides Tracker, the question came up early: should this just track ...
You’ve done the research. You’ve chosen your peptides. Maybe you’ve even reconstituted your first vial. Now comes the ...
If you’re running a peptide protocol — whether it’s BPC-157 for recovery, a CJC/Ipamorelin stack for growth hormone ...
The question of whether orally consumed peptides survive the gastrointestinal tract in biologically active forms is central to ...
This isn’t just a wellness story. It’s a political one. And it could determine the future of peptide ...
Latest News
